|
|
Article: Biovest Becomes Charter Member of the Joint U.S.-Norway Cancer Research Program.
- Article from:
- Health & Beauty Close-Up
- Article date:
- August 8, 2008
CopyrightCOPYRIGHT 2008 M2 Communications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
HEALTH AND BEAUTY CLOSE-UP-8 August 2008-Biovest Becomes Charter Member of the Joint U.S.-Norway Cancer Research Program(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com
Biovest International, a majority-owned subsidiary of Accentia Biopharmaceuticals, announced that Biovest has been designated one of the charter members of the Joint U.S.-Norway Cancer Research Program, a collaboration among leading pharmaceutical and biotechnology companies and research organizations with the vision of transforming world-class cancer diagnostics and treatments to improve and extend the lives of cancer patients.
The Joint U.S.-Norway Cancer Research Program will focus ...